Search

Renown Health is pleased to announce that Susan Lee, DO, MBA will serve as Chief Operating Officer for Renown South Meadows Medical Center. Dr. Lee begins her new role on March 7, and succeeds Chris Nicholas, who resigned last month for a position with a health system in Florida. Tony Slonim, MD, DrPH, President & CEO, Renown Health, announced Dr. Lee’s internal promotion today by writing, “Embracing our vision to improve the health of our community, we are empowering leaders to play a greater role in improving physician, employee and patient experiences; growing services to our community; providing Reliable and Exact Care and meeting rigorous standards for operational excellence and efficiency.” Dr. Slonim noted that he was excited as, “Dr. Lee expands her role, promotes a spirit of unity across the enterprise, and continues to make progress on achieving goals central to Renown’s success.” In her new role as Chief Operating Officer for Renown South Meadows Medical Center, Dr. Lee will work with Jennifer Allen, MSN, director of nursing and the South Meadows leadership medical staff and team to lead South Meadows to achieve its strategic and operational goals. Dr. Lee is an experienced, dynamic physician executive and operational leader with a record of service growth, clinical quality, patient communication and execution. She is experienced in cross-functional collaboration and nationally recognized for organizational change management. Board certified in Internal Medicine and Psychiatry, Dr. Lee has based her clinical practice as a hospitalist on the mind-body connection and a collaborative model with patients and families. Dr. Lee joined Renown Health as the Chair of Medical Specialties in the summer of 2020 to manage hospital-based physician practices. She was promoted to Chief Medical Officer for Renown Regional Medical Center in February 2021 to oversee inpatient clinical operations, including length of stay, hospital capacity, care management functionality, interdisciplinary rounds and Medical Staff services. Since September of 2021, as Chief Medical Officer for Renown Acute Care, she has been responsible for clinical operations, strategic direction, hospital-based physician management, the Medical Staff Office, regulatory standards, and quality and financial outcomes for Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Rehabilitation Hospital. Prior to serving at Renown, Dr. Lee served as Chief of Hospital Medicine at Carilion Clinic, a 7-facility nonprofit, integrated health system headquartered in Roanoke, Virginia. Dr. Lee is a graduate of the University of Massachusetts Amherst (MBA), Nova Southeastern University College of Osteopathic Medicine (DO) and Duke University (BA). She is an active member of the American College of Healthcare Executives and the American Association for Physician Leadership. Renown South Meadows Medical Center, located in south Reno, is a 76-bed acute care community hospital offering exceptional surgical and medical services in a nurturing environment. Renown South Meadows Medical Center is home to south Reno’s only 24/7 Emergency Department and staffed with Board-Certified Emergency physicians. Renown South Meadows Medical Center offers advanced care for patients including comprehensive primary care; x-ray and imaging services; lab services; heart care; OB/GYN; physical rehabilitation and pulmonary rehabilitation services; nuclear medicine and surgical services including orthopedics. As a not-for-profit organization, the Renown South Meadows Medical Center team embraces their role in improving the health and well-being of the people and communities served and provides necessary healthcare services regardless of race, creed, sex, national origin, handicap, age or ability to pay. In addition, Renown South Meadows Medical Center has been nationally recognized for providing the highest quality care and service, including: In U.S. News and World Report Best Hospital rankings, Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2020. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a High Performing rating were significantly better than the national average. Renown South Meadows Medical Center received The Joint Commission’s Gold Seal of Approval® accreditation for Total Knee Replacement, Total Hip Replacement and Total Shoulder Replacement and was recognized as Top Performer on Key Quality Measures.® Dr. Lee says she "understands that health care today is as much about social skills and navigating multiple relationships as it is about clinical knowledge." Throughout her career, Dr. Lee has done much to contribute to a culture of innovation and transformation. Dr. Lee believes that, “providers need physicians, nurses and care teams who have high adaptability, flexibility, and, above all, the ability to care and be kind." Dr. Lee coaches teams to be responsive, empathic, have situational awareness and employ their clinical abilities at the highest level. She will often ask questions of her team to understand how they are "wired" to drive innovation and transformation- and to build culture and teamwork. She has hired and coached over 100 hospitalist physicians — many of them women — and promoted and served as a reference for hundreds of nurses, staff leader and advanced care providers. Dr. Lee serves as a peer mentor for other women, and men, who aspire to physician and healthcare leadership. The team at Renown South Meadows Medical Center is seeking great employees for careers in service; apply on line at https://careers.renown.org/.

Read More About Dr. Susan Lee to Lead Renown South Meadows Medical Center

Experienced leader to support physicians at Renown Regional and Renown South Meadows Medical Centers Renown Health is pleased to announce that Adnan “Eddy” Akbar, MD, will serve as Chief Medical Officer for Renown Acute Care, overseeing physicians at Renown Regional Medical Center and Renown South Meadows Medical Center. Renown Health is the region's only Level II Trauma Center, serving more than 1 million people and a 100,000 square mile reach – across Nevada, Lake Tahoe and eastern California. Dr. Akbar begins his new role on July 25, succeeding former Chief Medical Officer for Acute Care, Dr. Susan Lee, who was promoted to Chief Operating Officer at Renown South Meadows Medical Center on March 7, 2022. Thomas Graf, MD, CEO for Renown Health, announced Dr. Akbar’s internal promotion today by writing, “Embracing our vision to improve the health of our community, we are empowering leaders to play a greater role in improving physician, employee and patient experiences; growing services to our community; providing Reliable and Exact Care® and meeting rigorous standards for operational excellence and efficiency.” Dr. Graf noted that he was excited as, “Dr. Akbar expands his role, promotes a spirit of unity across the enterprise, and continues to make progress on achieving goals central to Renown’s success.” In his new role as Chief Medical Officer for Acute Care, Dr. Akbar will join Dr. Rahul Mediwala, Chief Medical Officer for Health Services, to lead physicians and clinicians across the Renown enterprise. Dr. Akbar will report directly to Chris Nicholas, Chief Executive Officer for Renown Regional Medical Center. Dr. Akbar is an experienced, dynamic physician executive and operational leader with a record of hospital operations, medical staff leadership and engagement, quality improvement, patient safety, patient experience, risk management, utilization management and clinical documentation improvement. Chris Nicholas, Chief Executive Officer of Renown Regional Medical Center wrote, “Over the last seven years and through all the physician leadership positions he has held, Dr. Akbar has had an intense focus on improving patient care, driving hospital and operational improvements, and demonstrating the best of Renown’s mission, vision and values. Renown has a national reputation for delivering health care that is affordable, accessible and of the highest quality and I look forward to working with Dr. Akbar to engage physicians and administrators in an agenda that supports this vision.” Dr. Susan Lee, Chief Operations Officer of Renown South Meadows Medical Center added, “As we considered the needs of the organization and our future, we determined that Dr. Akbar was the right person to lead physicians across Acute Services. In addition, Dr. Akbar has demonstrated strong and engaging leadership with physicians, nurses, the senior management team and across our hospitals and we are confident in Eddy’s ability to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care.” Dr. Akbar has been with Renown Health for seven years, previously serving as Secretary of Medical Staff, an Internal Medicine physician, Chair of the Department of Medicine, Division Chief for Hospital Medicine and most recently as a hospitalist physician of Renown Medical Group and Associate Chief Medical Officer of Renown Regional Medical Center. Dr. Akbar is an Assistant Professor of Medicine at University of Nevada-Reno, School of Medicine and a member of the Clinical Faculty at St. Georges University School of Medicine, Grenada. Dr. Akbar is fluent in four languages including Urdu, Pushto and Hindi. Dr. Akbar completed his residency in internal medicine at Cleveland Clinic. He is a Diplomat of the American Board of Internal Medicine, and earned his medical degree from Aga Khan Medical College in Karachi, Pakistan. Dr. Akbar is completing his master’s in healthcare administration from Cornell University. Dr. Akbar’s research interests include observation criteria and appropriate utilization management of hospitalized patients, development and usage of dedicated Epic order sets to improve patient care and outcomes, advancement and development of Milestone appropriate care during acute hospitalization and transitional care policies to reduce hospital readmissions and improve patient care. In U.S. News and World Report Best Hospitals rankings, Renown Regional is #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News. Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2021. Renown Regional Medical Center is High Performing, its highest rating possible, for Heart Failure, Colon Cancer Surgery and Chronic Obstructive Pulmonary Disease. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a High Performing rating were significantly better than the national average. The team at Renown Health is seeking great employees for careers in service; apply online at https://careers.renown.org/. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

Read More About Adnan Akbar, MD, Appointed Chief Medical Officer for Renown Acute Care

Renown Health is pleased to announce that Samuel K. Weller, MHPA, will serve as Chief Executive Officer for Renown South Meadows Medical Center, a 118-bed acute care community hospital and Renown Rehabilitation Hospital, a 62-bed physical rehabilitation hospital in Reno, Nev. The position was formerly held by Chris Nicholas, FACHE, who was promoted in March 2022 to serve as CEO of 808-bed Renown Regional Medical Center in Reno. Renown Health is the largest and only locally owned not-for-profit, charitable healthcare network in Reno, serving over 1 million people and 100,000 square miles between Salt Lake City and Sacramento. As CEO, Mr. Weller will work with the South Meadows and Rehabilitation leadership, medical staff, and team to achieve patient care, efficiency, and operational goals.  “We are excited to have Sam join the Renown Health senior leadership team at this pivotal moment in our history,” said Dr. Brian Erling, Renown’s president and CEO. “Sam is a dyamic health care executive with a solid record of advancing acute and ambulatory operations while collaborating with physicians and clinicians to expand services, enhance clinical quality, and exceed customer service expectations. Sam leads with integrity and a people-first approach which are essential to deliver on our mission to improve the health and well-being of the people and communities we serve.” Mr. Weller comes to Renown from Centura Health where he served as Group Vice President of Physician Enterprise for Greater Colorado and Kansas, overseeing physician services across a Level 1 Trauma hospital, eight Level III Trauma hospitals, two Critical Access/Trauma IV hospitals and numerous primary care and specialty practices. He previously served as Director of Strategy and Ambulatory Practices for St. Anthony Summit Medical Center in Summit County, CO overseeing hospital and ambulatory operations for the Rocky Mountain region; and Group Manager Business Development in Denver. Mr. Weller is a graduate of Washington State University with a master’s degree in health policy and administration (MHPA) and a Bachelor of Science degree in Business Finance from Brigham Young University-Idaho. “I love health care because it is about people helping people,” says Sam Weller. “Renown is the most valued and trusted system of health for northern Nevadans, and working together, I am excited to help transform care for our community and improve the quality of life for generations to come.”  South Reno continues to grow, and consumer demand continues to increase for Renown medical providers and facilities. The South Meadows campus, which opened more than 15 years ago in February 2004, is currently improving existing facilities, and expanding service offerings to meet expressed needs of the community. Renown South Meadows Medical Center features private patient rooms for hospital stays, and will add additional private rooms, bringing the total to 73 private rooms when work is done this September.  Weller will assume his new duties on June 26.  Renown South Meadows Medical Center has been nationally recognized for providing the highest quality care and service.  In U.S. News and World Report Best Hospital rankings, Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2020. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety, and volumes. Hospitals earning a High Performing rating were significantly better than the national average. Renown Regional Medical Center was listed #1 for the State of Nevada in U.S. News and World Report Best Hospital listing for 2021 and 2022.  Sam and the team at Renown South Meadows Medical Center and Renown Rehabilitation Hospital are hiring great physicians, nurses and associates for careers in service; apply online at renown.org/careers, and volunteers to assist patients and their families at renown.org/About/Volunteers. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 associates, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently hiring great physicians, nurses and associates for careers in service; apply online at renown.org/careers and volunteers to assist patients and their families at renown.org/About/Volunteers.

Read More About Samuel K. Weller Appointed CEO for Renown South Meadows Medical Center and Renown Rehabilitation Hospital

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Chuck Podesta, national IT leader to use technology to improve the health and well-being of Nevadans. Renown Health is pleased to announce Charles (Chuck) Podesta has been named Chief Information Officer. Podesta is a seasoned executive with over 30 years of experience leading some of the nation’s top healthcare IT teams. He has literally worked from coast to coast and is excited to bring his talents to Nevada. “We are pleased to bring an experienced and talented leader like Chuck Podesta to lead our information and technology areas at Renown,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “As Chief Information Officer, he will have the opportunity to foster a culture of innovation and excellence in information technology which serves hundreds of thousands of people across the state and the nation. Chuck will use the power of technology to bring a new level of convenience to patients and providers and will use his talents and team to improve the health and well-being of Nevadans.” Chuck most recently served as Interim Chief Information Officer for UCONN Health’s John Dempsey Medical Center, School of Medicine and Clinical Research IT. Prior to that, Chuck served as CIO for UCI Health/UC Irvine School of Medicine and the University of California Health System. He also served as CIO for University of Vermont Health Network/Fletcher Allen Health; Steward Health/Caritas Christi Healthcare; Berkshire Health; Baystate Health and UMASS Medical Center, all in the New England area. Podesta specializes in creating, resourcing and implementing strategic technology plans; maximizing the power of the Epic electronic medical record; streamlining governance and priorities; aligning IT and medical informatics needs across affiliated entities including a medical school environment, Accountable Care Organizations (ACOs), Clinically Integrated Networks (CINs) and medical practices; partners to implement best of breed customer-driven digital tools; leads participation in state-wide health exchanges (HIE) and coaches and mentors IT teams.   “Chuck’s experience and strengths in a variety of diverse and complex environments make him the perfect leader for us at this important time in our history,” explains Josiah (Sy) Johnson, Chief of Staff for Renown. Chuck will assure we are leading with innovative and contemporary approaches and integrating technology and expertise in our ongoing pursuit of excellence in improving health and healthcare in Nevada. “I am honored and excited to join the Renown Health family and the northern Nevada community,” says Chuck Podesta, Chief Information Officer. “I am impressed with the innovation and transformation at Renown; which has earned it a reputation as one of the nation’s leading health systems. I look forward to joining Renown Health at this exciting time in its history. I am excited to bring my skills and experience to create a positive experience when people use our technology. I am looking forward to leading the organization on this important journey.” Podesta is a graduate of the Massachusetts College of Liberal Arts and an active member of CHIME, HIMSS and the Society for Information Management (SIM). Podesta will begin at Renown on July 12.   About Renown Health Renown Health is the region’s largest, local not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Health Welcomes New Chief Information Technology Officer

Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project.  The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix.  Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed.  According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening.  “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients.  “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study,  Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169.  This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.

Read More About Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result

Renown Health is pleased to announce the appointment of Anna Loomis, MBA, as its new Chief Financial Officer (CFO), effective July 1, 2024. Ms. Loomis will oversee all aspects of financial management for Renown Health including budgeting, financial planning, revenue cycle management, supply chain and strategic investments for Nevada’s #1 ranked health care organization.    Before joining Renown, Ms. Loomis served as Senior Vice President (SVP) and CFO with Portland-based Legacy Health, and prior to that as SVP and Chief Financial Officer for Washington-based MultiCare for more than 15 years.  With over 20 years in finance leadership and strategy, Ms. Loomis has led several transformative efforts to strengthen the organizations and build partnerships.    “We are thrilled to welcome Anna Loomis to our executive team,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “Anna is an approachable, innovative, and resilient leader. Her proven track record of financial stewardship and her deep understanding of the complexities of the healthcare landscape make her an ideal fit for the team. The essential role that Renown Health plays as the only local, not-for-profit, charitable healthcare network in Washoe County will be furthered by her commitment. We are confident that with her guidance and expertise, we will continue to strengthen our financial position while advancing our mission to deliver the highest quality care and service to patients.”    Anna earned her master’s and bachelor’s degree in business administration from Pacific Lutheran University (Tacoma, WA); completed a finance fellowship with The Academy GE Fellows Program and serves on the Board of Directors for PacificSource health plans.   As of Aug. 2023, Fitch Ratings affirmed the 'A+' long-term rating on the series 2020A, 2020B, 2015A and 2016A bonds issued on behalf of Renown Health, NV by Public Finance Authority (Renown Regional Medical Center Project). In addition, Fitch has affirmed Renown's IDR at 'A+'. Renown's 'A+' revenue bond ratings and the Outlook revision to Stable are primarily driven by the system's midrange operating risk profile assessment, which has rebounded significantly over the past 12-months. Both the rating and Stable Outlook incorporate Renown's position as the service area's single largest provider of high-end acute care services and maintenance of the leading market position, with approximately two-thirds of all patients in northern Nevada seeking care at Renown. The rating is further informed by Renown's solid balance sheet metrics, which remain intact at or near historical levels. Given significant consumer demand for Renown providers and services, a master facility planning process and strategic planning process has been undertaken to ensure that Renown has adequate bed and procedure capacity, spaces to accommodate new technology and services to meet the needs of a growing patient base and community. As the region’s only Level 2 Trauma Center for both adults and children, Renown serves over 1 million people and 100,000 square miles across Nevada, Lake Tahoe, and northeast California. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center has been named #1 in the State of Nevada for the last three years.   Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Renown Health Appoints Anna Loomis MBA As Chief Financial Officer

Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.” The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases.  About NAFLD and NASH NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. About one-third of people with NASH develop cirrhosis or irreversible liver damage (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.Media Contact for Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Read More About Renown Institute Expands Partnership to Offer ELF Testing

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results